Our previous data also showed that DEK protein was strongly positive in breast cancers and DCIS (ductal carcinoma in situ), but negative in normal breast glands, demonstrating that DEK protein expression levels might be used as a biomarker for early diagnosis of breast cancers[30]. This evidence concerns the gene DEK and ductal breast carcinoma in situ.